Photo - Gaston Ai
62429

Gaston Ai

United Kingdom
Market: Artificial Intelligence
Stage of the project: Prototype or product is ready

Date of last change: 20.11.2024
Go to the owner's profile
1
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

Enhancing epigenetics through food & nutrition personalisations. Integrate our AI directly into your apps to boost longevity for your users.

Current Status

After pivoting to B2B model, we now have have 6 current and confirmed customers from food tech, grocery, restaurant chain and table reservation verticals.
Company turned revenue generating in the beginning of 2024 and now having access to 5.2M users in high-growth markets with zero marketing spend. In addition, company has received numerous accreditations and awards globally. Naming few:
- Most Innovative Service, Technology or Digital Solution Supporting Nutraceutical Industry
- Best Dietary Specific Tech 2024
- Excellence Award for Personalised Nutrition Technology 2024

Problem or Opportunity

Non-communicable diseases (NCDs) cost UK over £130 billion each year which is a significant burden to the NHS. NCDs account for around two-thirds of deaths worldwide. Smart data correlations and AI can help understand and optimise targeted intake of nutrients in individuals diets. By analysing predispositions to illnesses, we want to create food maps that contain right nutrients responsible for preventing NCDs.

By intervening early with food as medicine using AI, our solution will have true potential to prevent around 40% of premature mortality in the UK caused by preventable NCDs.

Solution (product or service)

Users’ biomarkers are essential for identifying their current-and-future health conditions. We analyse macro, micro and phytonutrients of millions of foods and ingredients. We also analyse users’ health parameters using static and dynamic data that we collect via health (and nutrition) surveys, wearable devices and blood tests.

We’re training AI to analyse users’ predispositions to illnesses and generate highly-personalised food and nutrient recommendations based on their dietary, nutritional, medical and metabolic profiles. Using food-as-medicine, we want to prevent development of NCDs

Business model

We operate with a B2B SaaS model with 2 key distinct revenue streams.

Revenue stream 1: This is our core revenue model attributed to providing food and nutrition personalisation APIs. The model involves a fixed SaaS fee of £1 per user per month plus 0.5 pence per API call.

Revenue stream 2: As part of our product development, we are developing large data lakes of various types of data. We provide analytics to our customers via APIs. We charge £0.0005 per data click.

Incubation/Acceleration programs accomplishment

AWS SaaS Accelerator
Google AI
Barclays Eagle Labs
Virgin Empower100
InnovateUK EDGE
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility103
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Product Video
Presentation